Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Inari Medical, Inc. (NARI) is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, its dependency on the adoption of products is concerning. Shares of this Zacks Rank #3 (Hold) company have lost 29.2% year to date against the industry's 9.2% growth. The S&P 500 Index has risen 16.3% in the same time frame. NARI, with a market capitalization of $2.63 billion, is a commercial-stage medical device company. It seeks to d ...